White papers and other resources

Scientific journals

Conference posters

April 17, 2023
AACR 2023
The Xerna™ TME Panel potentially predicts response to a combination of the TLR9 agonist vidutolimod and PD-1 inhibitor pembrolizumab in metastatic melanomas with prior anti-PD-1 treatment
April 5, 2023
HubXchange 2023
ResponderID™: The Biology-First Machine Learning Platform for Biomarker Discovery
November 30, 2022
SITC 2022
Xerna tumor microenvironment subtypes as a biomarker in lung cancer patients
September 30, 2022
ESMO 2022
Predicting benefit from maintenance durvalumab after first-line chemotherapy (1L CTx) in oesophagogastric adenocarcinoma (OGA) using a novel tumour microenvironment (TME) RNA assay
April 11, 2022
AACR 2022
Xerna™ TME Panel: A pan-cancer RNA-based investigational assay designed to predict patient response to angiogenic- and immune-targeted therapies
April 12, 2021
AACR 2021
RNA-Based Diagnostic Panel Matches TME Phenotype to Therapeutic Mechanism of Action in Colorectal Cancer
November 10, 2020
SITC 2020
Development of an RNA-based Diagnostic Platform Based on the Tumor Microenvironment Dominant Biology